Cardiac Autonomic Denervation for Cardio-inhibitory Syncope
NCT05572034 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45
Last updated 2023-08-18
Summary
Background: Autonomic system modification is an established therapeutic approach that has been increasingly used for the treatment of vagal-related symptomatic bradycardia, such as cardio-inhibitory vasovagal syncope1-12.
Although convincing results had been reported from small populations, a large randomized study providing robust evidence on the efficacy of this approach has not yet been performed.
Hypothesis: Cardiac autonomic system modification is effective for the treatment of vagal-related symptomatic bradycardia, and is associated better clinical results as compared to placebo.
Conditions
- Bradycardia; Syncope
- Syncope, Vasovagal
Interventions
- PROCEDURE
-
Electrophysiological study
Electrophysiological study: patients in a fasting state and under total intravenous anesthesia Intracardiacelectrogramsare displayed simultaneously on a multichannel recorder. Programmed atrial and ventricular stimulation are performed to rule out sustained arrhythmias, primary conduction system dysfunction, and sick sinus syndrome.
- PROCEDURE
-
Electrophysiological study and Right side Ganglionated Plexi ablation
Electrophysiological study: patients in a fasting state and under total intravenous anesthesia Intracardiacelectrogramsare displayed simultaneously on a multichannel recorder. Programmed atrial and ventricular stimulation are performed to rule out sustained arrhythmias, primary conduction system dysfunction, and sick sinus syndrome. GP Mapping and Cardiac denervation: Specific atrium sites are empirically identified as GP by presumed anatomic location based on previous works (anatomic mapping): In the RA: the posterior aspect of the interatrial septum, between the posterior wall and coronary sinus ostium; and, the septal aspect of the superior vena cava junction (opposite to the LA GP tags). A 3.5-mm irrigated tip catheter will be used to deliver radiofrequency energy (50°C, 20-30 W, for 30-60 seconds) with a 17 mL/min irrigation flow.
- PROCEDURE
-
Electrophysiological study and bi-atrial Ganglionated Plexi ablation
Electrophysiological study: patients in a fasting state and under total intravenous anesthesia Intracardiacelectrogramsare displayed simultaneously on a multichannel recorder. Programmed atrial and ventricular stimulation are performed to rule out sustained arrhythmias, primary conduction system dysfunction, and sick sinus syndrome. GP Mapping and Cardiac denervation: Specific atrium sites are empirically identified as GP by presumed anatomic location based on previous works(anatomic mapping): In the LA: the inferior right GP (septal aspect of the right pulmonary veins \[PV\]) antra, and LA posterior wall. In the RA: the posterior aspect of the interatrial septum, between the posterior wall and coronary sinus ostium; and the septal aspect of the superior vena cava junction (opposite to the LA GP tags). A 3.5-mm irrigated tip catheter will be used to deliver radiofrequency energy (50°C, 20-30 W, for 30-60 seconds) with a 17 mL/min irrigation flow.
Sponsors & Collaborators
- collaborator INDUSTRY
-
University of Sao Paulo General Hospital
lead OTHER
Principal Investigators
-
Mauricio I Scanavacca, MD, PhD · University of Sao Paulo - General Hospítal
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2023-09-01
- Primary Completion
- 2023-12-30
- Completion
- 2024-03-30
Countries
- Brazil
Study Locations
More Related Trials
-
Efficacy of Transcatheter Ablation Using Anatomic Approach of Ganglionated Plexi Located in the Right Atrium to Prevent Neuromediated Cardioinhibitory Syncope
NCT01814228 ·Status: COMPLETED ·Phase: NA
-
National Registry of Cardioneuroablation in Recurrent Reflex Syncope
NCT06159764 ·Status: RECRUITING
-
Cardioneuroablation and Ventricular Proarrhythmia
NCT06458140 ·Status: RECRUITING ·Phase: NA
-
Guideline-based Pacing Therapy for Reflex Syncope
NCT01509534 ·Status: COMPLETED
-
Cardioneuroablation for Reflex Syncope and Exercise Capacity
NCT06440291 ·Status: RECRUITING ·Phase: NA
-
Prevention of Syncope by Cardiac Pacing in Patients With Bifascicular Block
NCT01463358 ·Status: COMPLETED ·Phase: NA
-
POLish Registry of CArdioneuroablation and CArdioneuromodulation
NCT07196397 ·Status: RECRUITING
-
Cardioneuroablation for Bradyarrhythmia
NCT06288633 ·Status: RECRUITING ·Phase: NA
-
Prophylactic Substrate Ablation in Post-myocardial Patients Undergoing Defibrillator Implantation.
NCT02780947 ·Status: UNKNOWN ·Phase: NA
-
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
NCT01013714 ·Status: RECRUITING ·Phase: PHASE3
-
Optimizing Diagnostics Of Syncope Events Using Intelligent Telemetric Solutions.
NCT01265290 ·Status: UNKNOWN ·Phase: NA
-
Electrophysiological Mechanisms and Inhibitory Cardiac Syncope
NCT02861274 ·Status: COMPLETED ·Phase: PHASE1
-
Bradycardia Risk Stratification With Loop Recorder After Syncope
NCT04200014 ·Status: UNKNOWN
-
Diagnosis of Arrhythmias in Syncope by Pocket-ECG III® or Conventional Holter
NCT02614235 ·Status: COMPLETED ·Phase: NA
-
Mobile Cardiac Outpatient Telemetry for Unexplained Syncope
NCT05957315 ·Status: UNKNOWN ·Phase: NA
-
Effect of Closed Loop Pacemaker Treatment on Recurrent Vasovagal Syncope
NCT00292825 ·Status: COMPLETED ·Phase: NA
-
Comparison of the Efficacy and Safety of Cardioneuroablation to Permanent Pacing in Patients With an Implanted Pacemaker for Symptomatic Bradycardia.
NCT05896592 ·Status: RECRUITING ·Phase: NA
-
Prognostic Value of Sympathetic Modulation in Patients With Heart Failure
NCT02047409 ·Status: UNKNOWN
-
Identifying High Risk Patients With Syncope
NCT00005202 ·Status: COMPLETED
-
Risk of Syncopal Relapses in Patients Treated With Permanent Pacing for Bradyarrhythmic Syncope
NCT04229589 ·Status: UNKNOWN
-
Telemetric Arrhythmia and Syncope Diagnosis - Evaluation of Arrhythmia Treatment Efficacy
NCT01265303 ·Status: UNKNOWN ·Phase: NA
-
Renal Denervation in Patients With Heart Failure With Normal LV Ejection Fraction
NCT02115230 ·Status: UNKNOWN ·Phase: NA
-
Noninvasive Measurement of Sympathetic Nerve Activity in Healthy Volunteers
NCT02264262 ·Status: COMPLETED ·Phase: NA
-
Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
NCT03453645 ·Status: UNKNOWN
-
Syncope: Pacing or Recording in the Later Years
NCT01423994 ·Status: COMPLETED ·Phase: PHASE4